Hillary’s plan will demand a stop to excessive profiteering and marketing by denying tax breaks for direct-to-consumer advertising and demanding that drug companies invest in R&D in exchange for taxpayer support – rather than marketing or excessive profits. She will encourage competition to get more generics on the market and create a Federal backstop for when there are excessively high-priced drugs that face no competition.
- She also needs democrats in majority in congress to pass any new laws. So this may come into play only when she wins + Democrats majority.
- Also compared to Trump, she has received more donations from Pharma companies. So this all may be an election talk.
- Which Indian Pharma companies produce drugs that have no competition?
- Forcing companies for more R&D - Will this benefit companies like Take Solutions?